Cramer's Big Pharma Play: JNJ

If investors are looking for a big pharma play that hasn't already run up, then go bottom feeding with Johnson & Johnson, says Mad Money's Jim Cramer. It's not the best company in the business, but there are many positives in its future.

CNBC | January 25, 2012

Tags:. .jnj. .pharma. .hasnt. .bottom. .feeding